InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,011.59
(
0.27%
)
US TECH 100
20,539.70
(
-0.13%
)
Dow Jones
44,350.79
(
0.82%
)
Brent Oil
71.73
(
-2.68%
)
Bitcoin
84,480.23
(
4.97%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

JJM760

Send PM Follow Ignore
Followers 5
Posts 993
Boards Moderated 0
Alias Born 06/15/2010

JJM760

Re: DonShimoda post# 23200

Monday, 10/22/2012 12:10:23 PM

Monday, October 22, 2012 12:10:23 PM

Post# of 80490
Ponatinib could well become a mega hit. Unfortunately all of these trials for the multiple indications will be a substantial drain both time wise and financially. IMO, the truth of the matter is Ponatinib would be better suited in the hands of a BP with deep pockets to fund these trials? It will take Ariad a very long time to get these indications to market. I just don't know if they have the capability to take it to the next level fast enough. I wonder if that comes into the equation at some point.

Just thinking out loud.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up